ImmunoQure AG and Servier enter into strategic partnership for the development of an Interferon-alpha human autoantibody
Düsseldorf, Germany & Paris, France (ots) - ImmunoQure, a biotech company focused on the research and development of human autoantibodies as therapeutics for the treatment of common human diseases and the international pharmaceutical company Servier today announced the establishment of a Worldwide, exclusive ...
mehr